MŞMerve Karaca Şahin

Merve Karaca Şahin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Merve Karaca Şahin has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Knowledge, clinical practices, and perceived self-efficacy regarding cow’s milk protein allergy among family physicians and pediatricians: a cross-sectional survey study

    by Çağla Öztürk Turan, Nilay Çalışkan, Aslı Berivan Topçak, Güler Yıldırım, Merve Karaca Şahin, Hilal Güngör, Hamit Bologur, Muhammed Fatih Erbay, Hasan Tunç Şarman, Ömer Yılmaz Ulutaş, et al.

  • Open Access

    Factors Associated With Omalizumab Response in Chronic Spontaneous Urticaria: Are There Age‐Related Differences?

    by Güler Yıldırım Nalbant, Raif Coşkun, Nilay Çalışkan, Merve Karaca Şahin, Aslı Berivan Topçak, Muhammed Fatih Erbay, Çağla Öztürk Turan, Hilal Güngör, Hamit Boloğur, Hasan Tunç Şarman, et al.

    Aim: This study aimed to explore clinical and laboratory markers of omalizumab response in paediatric and adult chronic spontaneous urticaria (CSU) patients. Methods: The study included 32 children and 67 adults with CSU receiving omalizumab, and 29 paediatric and 30 adult healthy controls; associations with treatment response were evaluated. Results: In adults, higher baseline Systemic Inflammation Response Index (SIRI) (OR = 0.207, p < 0.001), monocyte count (OR = 0.276, p = 0.002), neutrophil‐to‐lymphocyte ratio (NLR) (OR = 0.455, p = 0.012), and Systemic Immune‐Inflammation Index (SII) (OR = 0.487, p = 0.022) were associated with lower odds of treatment response. In paediatric patients, higher baseline SII was significantly associated with lower odds of response (OR = 0.349, p = 0.040). Interaction analyses showed nominally significant age interactions for baseline SIRI (B = −0.169, p = 0.027) and monocyte count (B = −0.193, p = 0.025). During follow‐up, SIRI was lower in responders from baseline through 12 months in adults, and at 3 and 6 months in children. SII was lower in responders at baseline in adults, and at baseline, 3, and 6 months in children (all p < 0.05). Conclusion: Our findings suggest potential differences in the associations between inflammatory markers and omalizumab response across age groups, though further studies are needed to clarify age‐related differences.

  • Response to Malik Et al.

    by Nilay Çalışkan, Merve Karaca Şahin, Güler Yıldırım, Aslı Berivan Topçak, Sefika Ilknur Kökcü Karadag, Hasan Tunç Şarman, Muhammed Fatih Erbay, Hilal Güngör, Hamit Boloğur, Zeliha Ceyhan, et al.

  • Nocturnal enuresis in children with allergic disease: prevalence, phenotype, and ARIA severity analysis

    by Kökçü Karadağ, Şefika İlknur, Bahar Eda Küçük, Bahar Eda, Aslı Berivan Topçak, Aslı Berivan, Muhammed Fatih Erbay, Çağla Öztürk Turhan, Nilay Çalışkan, Hamit Boloğur, et al.

  • Open Access

    Fear and picky eating‐related ARFID behaviors in children with food allergy

    by Merve Karaca Şahin, Nilay Çalışkan, Hasan Tunç Şarman, Çağla Öztürk Turan, Güler Yıldırım, Eren Güzeloğlu, Hilal Güngör, Aslı Berivan Topçak, Hamit Boloğur, Şule Papağan, et al.

    Background: Food allergy is a chronic condition with psychosocial consequences for both children and their families. Strict elimination diets and fear of adverse reactions may contribute to maladaptive coping including behaviors avoidant/restrictive food intake disorder (ARFID)‐related eating patterns. Therefore, this study aimed to compare ARFID‐related eating behavior scores between children with food allergy and healthy controls and to identify the affected domains. Methods: In this prospective controlled study, 234 children aged 2–9 years were enrolled, including 117 children with physician‐diagnosed food allergy and 117 age‐ and sex‐matched healthy controls. Eating behaviors were assessed using the Nine Item Avoidant/Restrictive Food Intake Disorder Screen—Parent Report (NIAS‐PR). Total and subscale scores (picky eating, fear, and appetite) were compared between groups. Within the food allergy group, associations between clinical characteristics and NIAS‐PR scores were analyzed. Results: Children with food allergy demonstrated significantly higher NIAS‐PR total scores compared with controls. The median total NIAS score was higher in the patient group than in the control group (17 [11–24] vs. 12 [7–18], p < .001). This difference was primarily driven by higher fear‐ and picky‐eating‐related scores, whereas appetite scores did not differ significantly. Fear subscale scores were significantly higher in children with a history of urticaria or anaphylaxis. Conclusion: Pediatric food allergy is associated with increased ARFID‐related eating behaviors, particularly fear‐ and picky‐eating patterns. In addition, fear‐related scores were higher among children with a history of immediate‐type reactions, such as urticaria and anaphylaxis. These findings suggest that ARFID‐related eating behaviors should be considered in the assessment of children with food allergy.


  • Open Access

    Parental self‐efficacy in food allergy management: Determinants and challenges

    by Nilay Çalışkan, Merve Karaca Şahin, Güler Yıldırım, Aslı Berivan Topçak, Sefika Ilknur Kökcü Karadag, Hasan Tunç Şarman, Muhammed Fatih Erbay, Hilal Güngör, Hamit Boloğur, Zeliha Ceyhan, et al.

    Background: Food allergy management requires dietary adherence, prevention of accidental exposures, and prompt reaction management. Identifying sociodemographic factors linked to low self‐efficacy may improve management. Methods: This study was conducted among parents of children diagnosed with food allergy who presented to our clinic. Participants completed the Turkish version of the Food Allergy Self‐Efficacy Scale for Parents (T‐FASE‐P, previously validated as EBA‐ÖZ) and the General Self‐Efficacy Scale (GSES). Results: A total of 280 parents (mothers, 85.4%; fathers, 14.6%) were included in the study. Of the children, 64.6% were boys and 35.4% were girls. The median parental age was 33 years (20–59), and the median child age was 25.5 months (3–213). Parents of children with egg and cow's milk allergy had lower T‐FASE‐P scores, while carrying an epinephrine auto‐injector and baked egg tolerance were associated with higher scores ( p < .05). Lowest scores related to school safety, cross‐contamination, and travel. In multivariable analyses, only school attendance ( p = .004) and cow's milk allergy ( p = .002) remained significant. Subscale analyses showed that school attendance was associated with prevention and recognition/management ( p = .002), parental employment with social activities ( p < .001), and IgE‐mediated allergy with recognition/management ( p = .027), whereas cow's milk allergy was consistently associated with lower scores across all subscales ( p < .05). Conclusion: This study evaluated parental self‐efficacy in relation to demographics. Cow's milk allergy was associated with lower, and carrying an adrenaline auto‐injector with higher self‐efficacy. These findings emphasize the need for targeted support for families managing high‐risk allergens.


  • Combined Immunodeficiency Associated With MAP2K1 p. Tyr130His Variant in Cardiofaciocutaneous Syndrome: A Case Report With Literature‐Based Phenotypic Comparison

    by Şefika İlknur Kökcü Karadağ, Aslı Berivan Topçak, Yelda Türkmenoğlu, Biray Ertürk, Nilay Çalışkan, Hamit Bologur, Güler Yıldırım, Hilal Güngör, Merve Karaca Şahin, Muhammed Fatih Erbay, et al.

    Cardiofaciocutaneous syndrome (CFCS) is a RASopathy involving craniofacial, cardiac, cutaneous, and neurologic features. MAP2K1 mutations, particularly in the kinase domain, are linked to CFCS type 3. Immune dysfunction has not previously been reported with the p.Tyr130His variant. To describe the case of combined immunodeficiency (CID) associated with the MAP2K1 p.Tyr130His variant. A 4‐month‐old female with CFCS presented with recurrent infections, growth failure, and ectodermal findings. Immunologic workup revealed hypogammaglobulinemia, low T cell subsets, and absent vaccine responses. Genetic analysis identified the MAP2K1 p.Tyr130His variant. She was started on intravenous immunoglobulin and prophylaxis, with clinical improvement. We describe a case of CID associated with the MAP2K1 p.Tyr130His variant adding to the growing evidence of immune dysregulation in CFCS.

  • Diagnosis of Paediatric Inborn Errors of Immunity in a MENA Cohort Referred for Recurrent Infections Using a Structured Clinical Algorithm: A Real‐Life Cross‐Sectional Study

    by Şefika İlknur Kökcü Karadağ, Aslı Berivan Topçak, Biray Ertürk, Nilay Çalışkan, Hamit Bologur, Güler Yıldırım, Hilal Güngör, Merve Karaca Şahin, Muhammed Fatih Erbay, Hasan Tunç Şarman, et al.

    Aim: To evaluate the diagnostic yield and clinical triage performance of a structured, multistep algorithm in children referred for suspected inborn errors of immunity (IEI) due to recurrent infections. Methods: This single‐centre study included 705 children (0–18 years) referred for recurrent infections. All were screened using JMF and/or MENA criteria. Of these, 132 met at least one criterion and underwent stepwise immunologic evaluation, including advanced testing when indicated. Results: Of 705 children referred with recurrent infections, 132 (18.7%) met screening criteria and underwent structured immunologic evaluation. Inborn errors of immunity were diagnosed in 50 patients (7.1%), with a 71% diagnostic confirmation rate. Pathogenic variants were detected in 74%, immunoglobulin abnormalities in 78% and all showed lymphocyte subset disturbances. The most common classifications were antibody deficiencies (32%) and syndromic combined immunodeficiencies (28%). Half received intravenous immunoglobulin, and no mortality occurred during follow‐up. Conclusion: The structured diagnostic algorithm based on JMF and MENA criteria improved IEI diagnosis and enabled effective prioritisation of children presenting with non‐infectious immune phenotypes. This model reduced unnecessary testing, supported efficient allocation of limited resources and facilitated timely diagnosis. The approach offers a practical, cost‐effective solution particularly applicable in regions with high consanguinity rates and limited access to advanced immunologic diagnostics.


  • Fixed drug eruption induced by clarithromycin and paracetamol in a child

    by Merve Karaca Şahin, Aslı Berivan Topçak, Şefika İlknur Kökçü Karadağ, Hasan Tunç Şarman, Hilal Güngör, Deniz Ozceker


  • Triamcinolone and Dexamethasone Hypersensitivity: A Pediatric Case Report

    by Merve Karaca Şahin, Muhammed Fatih Erbay, Hamit Bologur, Nilay Çalışkan, Güler Yıldırım, Deniz Ozceker

    Although corticosteroids are frequently used locally and systemically for their anti‐inflammatory and immunosuppressive effects, hypersensitivity is rare. In our case, a 16‐year‐old girl experienced anaphylaxis after injection of triamcinolone acetonide. The diagnosis of an IgE‐mediated allergy to triamcinolone acetonide was confirmed through intradermal testing. Intradermal tests and drug provocation tests were performed against other corticosteroids, but only the provocation test with dexamethasone resulted in delayed urticaria. This case indicates the potential for different types of hypersensitivity reactions to both triamcinolone and dexamethasone. Consequently, the importance of a comprehensive allergic evaluation with other corticosteroids is emphasized when a corticosteroid allergy is suspected.